Medicare Proposes to Sharply Limit Coverage of the Alzheimer’s Drug Aduhelm
Medicare’s coverage decision is considered pivotal to the future of Aduhelm, which is priced at $28,200 a year per patient. ...
Medicare’s coverage decision is considered pivotal to the future of Aduhelm, which is priced at $28,200 a year per patient. ...
GlaxoSmithKline's (GSK) logo is seen at the pharmaceuticals company's research centre in Stevenage, Britain, November 26, 2019. REUTERS/Peter Nicholls/File PhotoDec ...
Dublin, Aug. 12, 2021 (GLOBE NEWSWIRE) -- The "Hydrogel-based Drug Delivery System Market Size, Share & Trends Analysis Report by ...
A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike BlakeJuly 19 (Reuters) - U.S. ...
The Food and Drug Administration’s approval of Biogen Inc.’s BIIB -0.12% Aduhelm on Monday may have boosted the prospects of ...
The Biden administration is considering requiring tobacco companies to reduce the nicotine levels in all cigarettes sold in the U.S. ...
Shares of Myovant Sciences soared 27% Monday, after its parent Sumitovant Biopharma unveiled an agreement with Pfizer Inc. to jointly ...
© 2020 Marketofbusiness.com
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
Thank you for subscribing.
Something went wrong.
We respect your privacy and take protecting it seriously